MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity
Molecular Diagnosis · 2003
DOI: 10.1007/bf03260016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diagnosis, 2003. Verfasst von Andrew Pachner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 08540, USA. pachner@um…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 08540, USA. pachner@umdnj.edu
Zitieren
APA
Pachner, A., Narayan, K., Price, N., Hurd, M., & Dail, D. (2003). MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity. Molecular Diagnosis. https://doi.org/10.1007/bf03260016
Vancouver
Pachner A, Narayan K, Price N, Hurd M, Dail D. MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity. Molecular Diagnosis. 2003. doi:10.1007/bf03260016
BibTeX
@article{Pachner2003,
author = {Pachner, Andrew and Narayan, Kavitha and Price, Nicholson and Hurd, Marie and Dail, Donna},
title = {MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity},
journal = {Molecular Diagnosis},
year = {2003},
doi = {10.1007/bf03260016}
}
EUVIMED